Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10858339 Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Patent 10858339 was granted and assigned to Aerie Pharmaceuticals on December, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Aerie Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10858339

Date of Patent

December 8, 2020

Patent Application Number

15941993

Date Filed

March 30, 2018

Patent Citations

‌

US Patent 10112920 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds

‌

US Patent 10174017 Dual mechanism inhibitors for the treatment of disease

Patent Citations Received

‌

US Patent 12018012 Aryl cyclopropyl-amino-isoquinolinyl amide compounds

‌

US Patent 11312700 Aryl cyclopropyl-amino-isoquinolinyl amide compounds

‌

US Patent 11427563 Aryl cyclopropyl-amino-isoquinolinyl amide compounds

‌

US Patent 11891376 Aryl cyclopropyl-amino-isoquinolinyl amide compounds

‌

US Patent 11590123 Ophthalmic compositions

‌

US Patent 11618748 Dual mechanism inhibitors for the treatment of disease

‌

US Patent 11707460 Ophthalmic compositions

Patent Primary Examiner

‌

John S Kenyon

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10858339 Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API